Biogen Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 71
- Published: March 2019
- Report Code: MLPH1307FSA
Biogen Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Biogen Inc (Biogen) is a biopharmaceutical company that discovers, develops and delivers drugs for the treatment of neurological and neurodegenerative diseases. The company’s marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Fampyra (prolonged-release fampridine tablets) and Plegridy (peginterferon beta-1a) for the treatment of multiple sclerosis (MS); Spinraza (nusinersen) for spinal muscular atrophy (SMA); and Fumaderm (fumaric acid esters) for severe plaque psoriasis. The company also offers biosimilars through its joint venture, Samsung Bioepis. It has several product candidates targeting various indications such as MS, Parkinson's disease, Alzheimer’s disease and idiopathic pulmonary fibrosis, and stroke among others. The company sells its products through direct sales forces, marketing groups and distributors in the Americas, Europe, Asia and other territories. Biogen is headquartered in Cambridge, Massachusetts, the US.
Scope
Detailed information on Biogen Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Biogen Inc in the form of a SWOT analysis
An in-depth view of the business model of Biogen Inc including a breakdown and examination of key business segments
News about Biogen Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Biogen Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Biogen Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Biogen Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Novartis AG
Merck & Co Inc
United Neuroscience Ltd
Teva Pharmaceutical Industries Ltd
Bayer HealthCare Pharmaceuticals
Pfizer Inc
Sanofi
Dart NeuroScience LLC
Alzheon Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.